Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas

MLA

Xiaolin Zheng, et al. “Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas.” Molecular Medicine, vol. 14, Jan. 2008, pp. 264–75. EBSCOhost, https://doi.org/10.2119/2007-00101.yu.

APA

Xiaolin Zheng, Carol D. Swartz, Shantelle Lucas, Darlene Dixon, Linda Yu, Xudong Di, Stanley J. Robboy, Katrin Saile, Grace E. Kissling, & Hong He. (2008). Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas. Molecular Medicine, 14, 264–275. https://doi.org/10.2119/2007-00101.yu

Chicago

Xiaolin Zheng, Carol D. Swartz, Shantelle Lucas, Darlene Dixon, Linda Yu, Xudong Di, Stanley J. Robboy, Katrin Saile, Grace E. Kissling, and Hong He. 2008. “Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas.” Molecular Medicine 14 (January): 264–75. doi:10.2119/2007-00101.yu.